Clinical Trials Logo
  1. Home
  2. Hematologic Cancer
  3. NCT06053918

Research-Action in Hematology From Hospitalization to Home — RAH HD  

Hematologic Cancer Clinical Trial

Official title:
Psychological Follow-up in a Protected Hematology Unit as a Transitional Device Between Hospitalization and Return Home

Clinical Trial Summary

Objective : To study and support the hospitalization and the return home of patients with the help of a psychological follow-up started in a hospital institution and which will continue in the patient's home, based on the concepts of transitionality and narrativity. Material and method To do this, the subjects will benefit from psychological interviews where they will freely discuss what concerns them, whether it is illness, treatment, returning home, or any other personal subject. They will be divided into two groups of 5 patients each, one of the groups will benefit from follow-up in an institution as contracted for several years between the Institute of Hematology and the psychologists of the UMDSP, another from the same follow-up but with the presence of the psychologist at the time of discharge extended to the patient's home after leaving the hospital for a period of 2 months. To ensure a certain consistency in the evaluation criteria, these will be standardized in the form of questionnaires completed blindly by the patient, a caregiver and the investigator, at 3 key times of the research (entry, discharge from hospital, two months after this discharge) Device tested: The aim of this work is to test the benefits of a device based on transitionality, which can limit, thanks to the restoration of the symbolization process, the deleterious effects of each of the stages imposed by the disease, the care and the resumption of autonomy once the active phase of care has passed. Narrativity is also at the heart of this transitional device. It makes it possible to evoke the present experience of the patient in connection with future projects and in the continuity of past, potentially traumatic events. It opens onto a dynamic temporal perspective where the trauma freezes. The whole process promotes the subjective reappropriation of the experience and a psychic well-being.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06053918
Study type Observational
Source University Hospital, Caen
Contact
Status Completed
Phase
Start date May 7, 2019
Completion date March 31, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT04966156 - Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT N/A
Recruiting NCT05942885 - Hypnosis: a Path to Appeasement N/A
Recruiting NCT05715047 - Intervention for Fatigue in HCT Recipients N/A
Recruiting NCT05142033 - Avera Cancer Sequencing and Analytics Protocol (ASAP)
Recruiting NCT05175508 - Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS Phase 2/Phase 3
Not yet recruiting NCT04822974 - TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRS N/A
Not yet recruiting NCT06279585 - Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD N/A
Recruiting NCT05753501 - Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies Phase 1
Recruiting NCT05481502 - An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors N/A
Not yet recruiting NCT04412135 - The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality
Not yet recruiting NCT06377059 - Early Detection of Complications During Immunotherapy for Haematological Malignancy N/A
Completed NCT04235153 - CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients
Recruiting NCT05626764 - QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management
Active, not recruiting NCT04035447 - Symptom Management for YA Cancer Survivors N/A
Not yet recruiting NCT05602168 - Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance N/A
Terminated NCT03955276 - An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)
Recruiting NCT03091933 - Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) Phase 1/Phase 2
Withdrawn NCT01792882 - Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples
Recruiting NCT05493800 - Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT Phase 2
Active, not recruiting NCT05690230 - Improving Patient Experience: BMBA N/A